AAAAAA

   
Results: 1-3 |
Results: 3
Phramacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose
Authors: O'Dwyer, PJ Szarka, C Brennan, JM Laub, PB Gallo, JM
Citation: Pj. O'Dwyer et al., Phramacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose, CLIN CANC R, 6(12), 2000, pp. 4692-4696
Population pharmacokinetic model for topotecan derived from phase I clinical trials
Authors: Gallo, JM Laub, PB Rowinsky, EK Grochow, LB Baker, SD
Citation: Jm. Gallo et al., Population pharmacokinetic model for topotecan derived from phase I clinical trials, J CL ONCOL, 18(12), 2000, pp. 2459-2467
Structure-based optimization of peptide inhibitors of mammalian ribonucleotide reductase
Authors: Pellegrini, M Liehr, S Fisher, AL Laub, PB Cooperman, BS Mierke, DF
Citation: M. Pellegrini et al., Structure-based optimization of peptide inhibitors of mammalian ribonucleotide reductase, BIOCHEM, 39(40), 2000, pp. 12210-12215
Risultati: 1-3 |